Microsoft word - research day 2009 final program.doc

OPHTHALMOLOGY RESEARCH DAY 2009
Four Points Sheraton – Bristol C Ball Room
Wellington Road - London, Ontario
Friday, November 6, 2009
8:30 a.m.
Registration -
10:50 a.m.
Intrastromal versus Topical
Four Points Sheraton
Moxifloxacin in a New Zealand White
Bristol C Ball Room
Rabbit Keratitis Model - T. Chan MD,
9:00 a.m.
Welcome - Dr. C. Hutnik
Chair, Research
11:00 a.m.
Aqueous Fluid Levels of Moxifloxacin
Following Intrastromal Injection in the
Moderator – Dr. C. Hutnik
Rabbit Model - J. Giroux MD, R. Mather
9:10 a.m.
CCTV versus Eccentric Viewing in AMD
- J. Baryla MD, W. Hodge MD
11:10 a.m.
The Relationship Between Retinal
Hemodynamic and Systemic Markers of
9:20 a.m.
Inhibitory Effect of Cx43 on Oxidative
Endothelial Function and Inflammation
Stress Induced VEGF Expression in
in Type 2 Diabetes – C. Hudson PhD,
Human Retinal Pigment Epithelial Cells
- S. Khimdas BSc (Hon), C. Hutnik MD
11:20 a.m.
Multi-Parameter Ocular Phenotyping in
9:30 a.m.
Role of Mechanical Adaptation in the
a Novel Memantine-Treated Mouse
Contact Lens Related Dry Eye
Model of Retinal Degeneration – T.
Symptoms – J. Chen MSc,
9:40 a.m.
A Review of the Incidence of Failure in
11:30 a.m.
Retinal Degeneration in Harlequin
DSAEK (Descemets Stripping
Carrier Mice: Functional Deficits in
Automated Endothelial Keratoplasty) in
Advance of Structural Loss – A. Laliberte
Southwestern Ontario - S. Shukla MD,
11:40 a.m.
The Utility of Dacryoscintigraphy in the
9:50 a.m.
Isolation and Characterization of a
Diagnosis and Treatment of Functional
Primary Culture of Bovine Trabecular
Nasolacrimal Duct Obstruction
Meshwork Cells Under Conditions of
Oxidative Stress - M. Feng,
11:50 a.m.
A Needs Assessment of Ophthalmology
Teaching in Undergraduate Medical
10:00 a.m.
Effect of Various Topical Steroid
Education and Family Medicine
Formulations on Myocilin Protein
Residency – E. Lee, C. Hutnik MD
Expression in Trabecular Meshwork
Cells - A. Kosaric MD, C. Hutnik MD
12:00 p.m.
10:10 a.m.
Determination of Albumin Sorption to
1:00 p.m.
GUEST SPEAKER
Intraocular Lenses by Radiolabeling and
Patterns of Ocular and Adnexal
Confocal Scanning Laser Microscopy -
Inflammation in Inflammatory Skin
Diseases – J. Heathcote PhD, FRCPC
1:30 p.m.
Collagen Expression in the Injured and
10:20 a.m.
Diseased Eye - J. Ho BHSc(Hons),
10:40 a.m.
Low-Literacy Written Patient Education
Materials - K. Visscher MScBMC,
1:40 p.m.
A Systematic Review of Glaucoma
Screening Technology -K. Warrian MD,
1:50 p.m.
Characterization of the Effects of
GUEST SPEAKER
Lacritin on Human Corneal Epithelial
J. G. Heathcote M.A., M.B. B.Chir., (Cantab.), Ph.D. Cells Exposed to Benzyalkonium
Chloride - N. Ashki PhD, C. Hutnik MD
Professor and Head, Department of Pathology Professor, Department of Ophthalmology & Visual 2:00 p.m.
Long Term Outcomes in Retinopathy of
Prematurity – A Southwestern Ontario
Head and District Chief, Department of Pathology and Experience - A. Pirbhai MD, S. Sharan
Laboratory Medicine, Queen Elizabeth II Health Sciences Centre and Capital District Health Authority. Halifax, 2:10 p.m.
Modeling the Flow and Fate of Ocular
Drugs Using Micro-CT – C. Smith MESc
RESIDENT RESEARCH PROJECT FACILITATORS
2:20 p.m.
The Influence of Near Adds on the
Ocular Motor Responses of Myopic
Children - V. Sreenivasan MSc,
2:30 p.m.
“Real-time” obstacle avoidance in the
absence of primary visual cortex -
LEARNING OBJECTIVES
• To provide the audience with information regarding current clinical, educational and basic science research 2:40 p.m.
Natural History of Conservatively
Managed Patients with Non-functional
• To update knowledge on new research techniques Pituitary Macroadenoma
• This one day event will be of interest to ophthalmologists, optometrists and allied health 2:50 p.m.
BREAK AND JUDGING
STUDY CREDITS
3:10 p.m.
Presentation of the Dr. C. A. Thompson
This event is an Accredited Group Learning Activity Award and Allergan Research Day
Award for Outstanding Research Day
(Section 1) as defined by the Maintenance of Certification Presentation by a Resident – C. Hutnik
program of The Royal College of Physicians and Surgeons of Canada. This program has been reviewed and approved by Continuing Medical Education, Schulich Presentation of the Merck Frosst
School of Medicine and Dentistry, The University of Undergraduate Medical Student Award
– C. Hutnik MD
Ophthalmology Research Day 2009 is organized by the
Presentation to Guest Judges
Ophthalmology Research Committee -
– C. Hutnik MD
3:30 p.m.
Adjournment – C. Hutnik MD
Each session will provide sufficient time for REGISTRATION FORMOPHTHALMOLOGY RESEARCH DAY FRIDAY, NOVEMBER 6, 2009
Name: ______________________________________________________ Telephone: _____________________________________ Mailing Address: ______________________________________________ E-Mail _________________________________________ I will attend the luncheon Yes _____
(Please let us know if you have any dietary restrictions) Note: You will NOT be receiving written acknowledgement of your regi PLEASE RETURN REGISTRATION FORM BY MONDAY, OCTOBER 26, 2009 TO
Laurie Dawe, Ivey Eye Institute, St. Joseph’s Health Care, London, Ontario N6A 4V2
Telephone: 519-646-6100 Ext. 65642 Fax: 519-646-6248 Email: [email protected]

Source: http://www.iveyeye.ca/downloads/events/release/2013/ivey-eye-event-doc_info_2013-01-JAN-17_opthalmology-research-day-2009_BD33B.pdf

Microsoft word - lectio.doc

Il contesto sociale, culturale, economico e politico «Educare alla vita buona del Vangelo» Roma - Domus Pacis Torre Rossa Park Hotel 7-9 febbraio 2011 Lectio - La parabola del seminatore MC 4,1-20 Questa mattina cercheremo di entrare all’interno di un brano evangelico molto noto e assai commentato, tenendo come chiave di lettura e punto di riferimento l’attenzione alle d

010302 a comparison of risperidone and haloperidol

The Ne w E n g l a nd Jo u r n a l o f Me d ic i ne A COMPARISON OF RISPERIDONE AND HALOPERIDOL FOR THE PREVENTION OF RELAPSE IN PATIENTS WITH SCHIZOPHRENIA JOHN G. CSERNANSKY, M.D., RAMY MAHMOUD, M.D., M.P.H., AND RONALD BRENNER, M.D., ABSTRACT Background lifetime prevalence of 0.7 percent in the Unit-of maintenance treatment in patients with psychoticed Sta

© 2010-2018 Modern Medicine